login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
GLOBAL BLOOD THERAPEUTICS IN (GBT) Stock News
USA
- NASDAQ:GBT -
US37890U1088
-
Common Stock
68.49
USD
+0.01 (+0.01%)
Last: 10/4/2022, 8:00:01 PM
68.49
USD
0 (0%)
After Hours:
10/4/2022, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
GBT Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Global Blood Therapeutics, Inc.
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
3 years ago - By: Investor's Business Daily
- Mentions:
CPRX
BMRN
VRTX
SRPT
...
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
3 years ago - By: Benzinga
Global Blood Therapeutics's Return On Capital Employed Overview
3 years ago - By: Benzinga
Global Blood Therapeutics's Return On Capital Employed Overview
3 years ago - By: Kahn Swick & Foti, LLC
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
3 years ago - By: Investor's Business Daily
- Mentions:
PFE
BMY
ALNY
KRTX
...
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
3 years ago - By: Bloomberg
- Mentions:
PFE
JNJ
Pfizer Bidding War With J&J Preceded Global Blood Therapeutics Deal
3 years ago - By: Investor's Business Daily
- Mentions:
ALC
AERI
BMY
AMGN
...
Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million
3 years ago - By: Investor's Business Daily
- Mentions:
PFE
Pfizer Inks $5.4 Billion Deal To Acquire Global Blood Therapeutics
3 years ago - By: Investor's Business Daily
- Mentions:
NVDA
MU
DIS
CELH
...
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
3 years ago - By: Kahn Swick & Foti, LLC
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT
3 years ago - By: Weiss Law
- Mentions:
PFE
SHAREHOLDER ALERT: Weiss Law Investigates Global Blood Therapeutics, Inc.
3 years ago - By: InvestorPlace
- Mentions:
TBLT
RDBX
REV
PETZ
...
TBLT, RDBX: The Top 5 Short Squeeze Stocks to Watch This Week
3 years ago - By: InvestorPlace
- Mentions:
PFE
GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics
3 years ago - By: Halper Sadeh LLP
Global Blood (GBT) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Global Blood Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GBT
Please enable JavaScript to continue using this application.
